Blog Big Molecule Watch October 06, 2020

Medicure International Enter Agreement with Reliance Life Sciences for Cardiovascular Biosimilar

Yesterday, Medicure, Inc. announced that its wholly-owned subsidiary, Medicure International Inc., has entered into a license, manufacture and supply agreement with Reliance Life Sciences Private Limited for a cardiovascular biosimilar. The identity of the biosimilar was not disclosed.  Medicure will be responsible for the regulatory approval process for the biosimilar.

The post Medicure International Enter Agreement with Reliance Life Sciences for Cardiovascular Biosimilar appeared first on Big Molecule Watch.